(Q51748581)

11 April 2018

meta-analysis

0 references

title

Association of C-reactive protein with type 2 diabetes: prospective analysis and meta-analysis. (English)

1 reference

11 April 2018

0 references

0 references

5

1 reference

11 April 2018

Robert N. Luben

7

1 reference

11 April 2018

Nicholas J. Wareham

10

object named as

N J Wareham

1 reference

11 April 2018

9

K T Khaw

1 reference

11 April 2018

Sheila Rodwell

8

object named as

S Bingham

1 reference

11 April 2018

author name string

C C Lee

1

1 reference

11 April 2018

A I Adler

2

1 reference

11 April 2018

M S Sandhu

3

1 reference

11 April 2018

S J Sharp

4

1 reference

11 April 2018

S Erqou

6

1 reference

11 April 2018

publication date

27 March 2009

1 reference

11 April 2018

published in

Diabetologia

1 reference

11 April 2018

volume

52

1 reference

11 April 2018

issue

6

1 reference

11 April 2018

page(s)

1040-1047

1 reference

11 April 2018

https://scigraph.springernature.com/pub.10.1007/s00125-009-1338-3

exact match

0 references

cites work

C-reactive protein and the development of the metabolic syndrome and diabetes in middle-aged men.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00125-009-1338-3

Metabolic obesity: the paradox between visceral and subcutaneous fat.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00125-009-1338-3

Elevated serum ferritin levels predict new-onset type 2 diabetes: results from the EPIC-Norfolk prospective study

21 January 2018

1 reference

12 December 2020

Adiponectin and the development of type 2 diabetes: the atherosclerosis risk in communities study

1 reference

12 December 2020

Adiponectin and protection against type 2 diabetes mellitus

1 reference

12 December 2020

Association between serum gamma-glutamyltransferase and C-reactive protein

1 reference

12 December 2020

gamma-Glutamyltransferase, obesity, and the risk of type 2 diabetes: observational cohort study among 20,158 middle-aged men and women

1 reference

12 December 2020

C-reactive protein inhibits adiponectin gene expression and secretion in 3T3-L1 adipocytes

1 reference

12 December 2020

Inflammatory markers and risk of developing type 2 diabetes in women

1 reference

12 December 2020

Gamma-glutamyl transpeptidase and the metabolic syndrome.

1 reference

12 December 2020

C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease

1 reference

12 December 2020

Three-year increase of gamma-glutamyltransferase level and development of type 2 diabetes in middle-aged men and women: the D.E.S.I.R. cohort.

1 reference

12 December 2020

Dietary fat and the risk of clinical type 2 diabetes: the European prospective investigation of Cancer-Norfolk study

1 reference

12 December 2020

Elevated C-Reactive Protein Is a Risk Factor for the Development of Type 2 Diabetes in Japanese Americans

1 reference

12 December 2020

EPIC-Norfolk: study design and characteristics of the cohort. European Prospective Investigation of Cancer

1 reference

12 December 2020

Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study

1 reference

12 December 2020

Absence of diurnal variation of C-reactive protein concentrations in healthy human subjects.

1 reference

12 December 2020

Liver enzymes, the metabolic syndrome, and incident diabetes: the Mexico City diabetes study.

1 reference

12 December 2020

Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies

1 reference

12 December 2020

Elevated C-reactive protein is a predictor of the development of diabetes in a general Japanese population: the Hisayama Study

1 reference

12 December 2020

Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study

1 reference

12 December 2020

High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH.

1 reference

12 December 2020

Measuring inconsistency in meta-analyses

1 reference

12 December 2020

Sex Differences in the Prediction of Type 2 Diabetes by Inflammatory Markers: Results from the MONICA/KORA Augsburg case-cohort study, 1984-2002

1 reference

12 December 2020

Prospective Relation of C-Reactive Protein With Type 2 Diabetes: Response to Han et al

1 reference

12 December 2020

Inflammatory markers, adiponectin, and risk of type 2 diabetes in the Pima Indian.

1 reference

12 December 2020

Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association

1 reference

12 December 2020

C-reactive protein as a predictor for incident diabetes mellitus among middle-aged men: results from the MONICA Augsburg cohort study, 1984-1998.

1 reference

12 December 2020

The association of serum gamma glutamyltransferase with components of the metabolic syndrome in the Korean adults

1 reference

12 December 2020

Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study

1 reference

12 December 2020

Adiponectin and development of type 2 diabetes in the Pima Indian population

1 reference

12 December 2020

Genetic variation, C-reactive protein levels, and incidence of diabetes.

1 reference

12 December 2020

Metabolic syndrome is directly associated with gamma glutamyl transpeptidase elevation in Japanese women

1 reference

12 December 2020

C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study

1 reference

12 December 2020

Relationship between adiponectin and glycemic control, blood lipids, and inflammatory markers in men with type 2 diabetes

1 reference

12 December 2020

C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus

1 reference

12 December 2020

Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study

1 reference

12 December 2020

Is type II diabetes mellitus a disease of the innate immune system?

1 reference

12 December 2020

Obesity is an important determinant of baseline serum C-reactive protein concentration in monozygotic twins, independent of genetic influences

1 reference

12 December 2020

The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study

1 reference

12 December 2020

Effect of hormone replacement therapy on inflammation-sensitive proteins in post-menopausal women with Type 2 diabetes

1 reference

12 December 2020

10.1007/S00125-009-1338-3

Identifiers

DOI

1 reference

11 April 2018

release_dfqffcufvfcajprajgja23675y

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/dfqffcufvfcajprajgja23675y

24 November 2022

mapped directly with Wikidata item

1 reference

11 April 2018